Critical congenital heart disease (CCHD) screening is a non-invasive test performed on newborns to detect serious heart defects that could lead to significant morbidity or mortality if not identified early. The screening typically involves pulse oximetry to measure blood oxygen levels, helping to identify infants who may need further diagnostic evaluation and intervention.